WHO Standards for Improving the Quality of Child Hospital Care

NCT ID: NCT06007287

Last Updated: 2024-03-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

880 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-01-07

Study Completion Date

2025-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Even in high-income countries, quality of pediatric health care has been described as substandard in many settings, resulting in worst health outcomes and increased cost for the health system. Nevertheless, still there is a paucity of studies documenting the quality of care for children in a comprehensive and systematic manner, using international standards, and validated data collection tools. The World Health Organization (WHO) developed three sets standards for improving the quality of maternal newborn and child health care. The aim of this study is to test the use of the WHO Pediatric standards for improving the quality of child hospital care, as summarized by a score of total mean quality score for patients (range 0-100 points).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Achieving the Sustainable Development Goal (SDG) goal 3 targets as elaborated in the WHO Global Strategy for Women's, Children's, and Adolescent's Health (2016-2030) will require ensuring universal access to safe, effective, quality and affordable care for women, children and adolescents. Despite the progress made in the last two decades, an estimated 6.6 million infants, children and young adults still died in 2016 (5.6 million children under five and 1 million children aged 5-14) mostly from preventable causes. To provide universal health coverage with quality, every woman, child and adolescent should receive quality care throughout their life course and during care. This requires institutionalization of safe, effective, quality service delivery.

Studies have shown that most often children do not receive basic elements of care or are often inappropriately managed, and their rights as patients are not respected. Therefore, urgent actions are required to ensure that the care given to all children in health facilities is evidence-based, safe, effective, timely, efficient, equitable and appropriate for their age and stage of development, and that care provided is child and family centred, and that all rights of children are respected. WHO recently launched (May 2018) the "Standards for improving quality of care for children and young adolescents in health facilities", to address the quality of care for children 0-15 years of age in health facilities. These pediatric Standards complement previous standards addressing quality of maternal and newborn care.

The WHO standards are based on a WHO paediatric quality of care framework, which highlights 8 specific domains of care that are critical to providing quality care for children (Fig. 1). These domains are organized into three main categories: provision of care (including: 1. Evidenced based practices; 2. Actionable information system; 3. Functioning referral system), experience of care (including: 4. Effective communication; 5. Respect, protection and fulfilment of child rights; 6. Emotional and psychological support) and availability of child- and adolescent-friendly resources (including 7. Competent, motivated, empathetic human resources and 8. Essential child and adolescent-friendly physical resources). The framework takes into account children's right to health and recognizes that their needs are different from those of adults.

Currently there is very limited field experience in the use of the WHO Standards for improving Quality of Care. More in general, routine use of data to improve case management and organization of care is still not a common practice, even in countries with well-established data collection systems. Despite there are some good examples of how routine data collection systems are used to shape health policies and strategies in the pediatric field in low and middle-income countries, these are quite limited in number, with most of the experience being conducted in a research/project setting.

he aim of this study is to test the use of the WHO Pediatric standards for improving the quality of child hospital care, as summarized by a score of total mean quality score for patients (range 0-100 points).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pediatric Hospital Care

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Service Users: parents/ other caretakers of children hospitalised in the Pediatric ward (ordinary hospitalization) and the pediatric emergency unit (brief intensive observation) between 0-15 years in all participating hospital
* Service Providers: all healthcare providers routinely assisting children in the participating units of the hospitals, namely: doctors, doctors in training, nurses

Exclusion Criteria

Service Users

* Parents/ caretakers with age \< 18 years
* Parents/caretakers of a child \> 15 years of age (WHO standards cover up to 15 years)
* Parents/ caretakers of deceased child or of a child admitted to intensive care at the time of administration of the questionnaire
* Parents/caretakers with concomitant serious psychiatric disorders
* Parents/caretakers of a child hospitalized at Child Neuropsychiatry or Surgery Department
* Parents/caretakers of a child hospitalized as a Day Hospital
* Parents/caretakers in surgery department/beds of neuro/psychiatric department/beds
* Parents//caretakers with primarily surgery serious psychiatric disorders
* Refusal to participate.

Service Providers

* Personnel not routinely involved in the overall clinical care
* Prolonged absence from work (eg maternity leave) and/or unavailability during the study period
* Personnel working only on surgical conditions or neuro/psychiatric, or other special
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

IRCCS Burlo Garofolo

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marzia Lazzerini, MD

Role: STUDY_CHAIR

IRCCS materno infantile Burlo Garofolo

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

IRCCS Burlo Garofolo

Trieste, , Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marzia Lazzerini, MD

Role: CONTACT

+390403785555

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marzia Lazzerini, MD

Role: primary

+390403785555

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RC 15/19

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.